Want to see ONCY full AI Analyst Report?
Oncolytics Biotech (ONCY) Income Statement
Oncolytics Biotech Income Statement
Last quarter (Q2 2026), Oncolytics Biotech's total revenue was $0.00. In Q2, Oncolytics Biotech's net income was $-9.44M. See Oncolytics Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 28.73M | $ 25.54M | $ 25.47M | $ 19.84M | $ 26.23M | |
| Depreciation and Amortization | $ 70.00K | $ 87.00K | $ 303.78K | $ 288.83K | $ 452.00K |
| $ -28.66M | $ -25.45M | $ -25.17M | $ -19.55M | $ -25.78M | |
| $ -28.73M | $ -25.54M | $ -25.47M | $ -19.84M | $ -26.23M | |
| $ 45.00K | $ 2.84M | $ 4.63M | $ 1.60M | $ -20.05K | |
| $ -28.68M | $ -22.70M | $ -20.85M | $ -18.24M | $ -26.25M | |
| $ -28.76M | $ -22.79M | $ -20.92M | $ -18.30M | $ -26.30M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.41 | $ -0.30 | $ -0.41 | $ -0.44 | $ -0.49 |
| Diluted EPS | $ -0.41 | $ -0.30 | $ -0.41 | $ -0.44 | $ -0.49 |
| Weighted Average Shares Outstanding | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M |
| Weighted Average Shares Outstanding (Diluted) | 95.86M | 76.48M | 67.62M | 58.03M | 53.51M |
Currency in CAD
